Mitochondrial pathology in Parkinson's disease and implications for therapeutic intervention

被引:0
作者
Swerdlow, RH [1 ]
Parker, WD [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Neurol, Charlottesville, VA 22908 USA
关键词
mitochondria; Parkinson's disease; mitochondrial DNA; therapy;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Although the ultimate origin and role of mitochondrial pathology in Parkinson's disease (PD) remains controversial, accumulating data suggest that mitochondrial dysfunction is genetic and plays an important role in neurodegeneration. PD mitochondria display abnormal electron transport chain activity, increased reactive oxygen species generation, and abnormal calcium handling. These abnormalities arise, at least in part, from information encoded by mitochondrial DNA. These processes are implicated in current models of neuronal death and validate ongoing efforts to develop mitochondrial-level pharmacologic interventions for the treatment of this disease. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:44 / 50
页数:7
相关论文
共 78 条
  • [21] MANGANESE AND CALCIUM EFFLUX KINETICS IN BRAIN MITOCHONDRIA - RELEVANCE TO MANGANESE TOXICITY
    GAVIN, CE
    GUNTER, KK
    GUNTER, TE
    [J]. BIOCHEMICAL JOURNAL, 1990, 266 (02) : 329 - 334
  • [22] GOLDBAUM L R, 1976, Annals of Clinical and Laboratory Science, V6, P372
  • [23] Mitochondrial defect in Huntington's disease on caudate nucleus
    Gu, M
    Gash, MT
    Mann, VM
    JavoyAgid, F
    Cooper, JM
    Schapira, AHV
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (03) : 385 - 389
  • [24] GU M, 1997, MOV DISORD S1, V12, P2
  • [25] LOW PLATELET MITOCHONDRIAL COMPLEX-I AND COMPLEX-II/III ACTIVITY IN EARLY UNTREATED PARKINSONS-DISEASE
    HAAS, RH
    NASIRIAN, F
    NAKANO, K
    WARD, D
    PAY, M
    HILL, R
    SHULTS, CW
    [J]. ANNALS OF NEUROLOGY, 1995, 37 (06) : 714 - 722
  • [26] RISK-FACTORS FOR PARKINSONS-DISEASE
    HUBBLE, JP
    CAO, T
    HASSANEIN, RES
    NEUBERGER, JS
    KOLLER, WC
    [J]. NEUROLOGY, 1993, 43 (09) : 1693 - 1697
  • [27] INCREASE OF DELETED MITOCHONDRIAL-DNA IN THE STRIATUM IN PARKINSONS-DISEASE AND SENESCENCE
    IKEBE, S
    TANAKA, M
    OHNO, K
    SATO, W
    HATTORI, K
    KONDO, T
    MIZUNO, Y
    OZAWA, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (03) : 1044 - 1048
  • [28] POINT MUTATIONS OF MITOCHONDRIAL GENOME IN PARKINSONS-DISEASE
    IKEBE, S
    TANAKA, M
    OZAWA, T
    [J]. MOLECULAR BRAIN RESEARCH, 1995, 28 (02): : 281 - 295
  • [29] UNALTERED ACONITASE ACTIVITY, BUT DECREASED COMPLEX-I ACTIVITY IN SUBSTANTIA-NIGRA PARS-COMPACTA OF PATIENTS WITH PARKINSONS-DISEASE
    JANETZKY, B
    HAUCK, S
    YOUDIM, MBH
    RIEDERER, P
    JELLINGER, K
    PANTUCEK, F
    ZOCHLING, R
    BOISSL, KW
    REICHMANN, H
    [J]. NEUROSCIENCE LETTERS, 1994, 169 (1-2) : 126 - 128
  • [30] JOHNS D R, 1991, Neurology, V41, P347